Data / Drug companies / BCN Peptides SA
BCN Peptides SA: 15 products in the FDA NDC directory, labeler code 35207
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
BCN Peptides SA (labeler code 35207) lists 15 products in the FDA National Drug Code Directory. By type: 15 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on June 15, 2026.
The request: Watch BCN Peptides SA (FDA labeler code 35207): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 35207
- Products in commercial distribution
- 15
- Packages
- 15
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- May 28, 2012
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 15 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 15 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 15 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Tetracosactide | 35207-0015 | Powder | Bulk ingredients | June 15, 2026 |
| Terlipressin | 35207-0014 | Powder | Bulk ingredients | April 7, 2026 |
| Protirelin | 35207-0013 | Powder | Bulk ingredients | March 14, 2024 |
| Alarelin | 35207-0012 | Powder | Bulk ingredients | June 8, 2022 |
| Lanreotide acetate | 35207-0011 | Powder | Bulk ingredients | August 28, 2018 |
| Ganirelix | 35207-0010 | Powder | Bulk ingredients | September 1, 2017 |
| Nesiritide | 35207-0009 | Powder | Bulk ingredients | September 1, 2017 |
| Leuprolide | 35207-0007 | Powder | Bulk ingredients | September 1, 2017 |
| Salmon calcitonin | 35207-0003 | Powder | Bulk ingredients | September 1, 2017 |
| Desmopressin acetate | 35207-0001 | Powder | Bulk ingredients | May 28, 2015 |
| Icatibant acetate | 35207-0008 | Powder | Bulk ingredients | July 22, 2014 |
| Octreotide | 35207-0002 | Powder | Bulk ingredients | November 12, 2013 |
| Corticotropin porcine | 35207-0006 | Powder | Bulk ingredients | October 31, 2012 |
| Vasopressin | 35207-0005 | Powder | Bulk ingredients | July 25, 2012 |
| Cosyntropin | 35207-0004 | Powder | Bulk ingredients | May 28, 2012 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.